Back to the main directory
Company Analysis / Equity
- BT Reports Fiscal 3Q Results That Are a Bit Weak, but Shares Remain Undervalued; Maintaining Our FVE by Morningstar
- BT Reports Fiscal 3Q Results That Are a Bit Weak, but Shares Remain Undervalued; Maintaining Our FVE by Morningstar
- ASM International in Position for Solid Near-Term Growth, Though Competition Looms on the Horizon by Morningstar
- Expense headwinds plague 2017 results, but order growth implies a better year ahead for Getinge. by Morningstar
- Raising AngloGold Ashanti’s FVE After Solid 3Q Puts It on Track for Improvement by Morningstar
- Asbury Weathers the Storms With Strong 3Q Margins by Morningstar
- Promotional cadence crimps Bed Bath’s profit; inability to take price reinforces our no-moat rating. by Morningstar
- Wide-moat Campbell's diversification efforts beyond soup accelerated with deal for Snyder's-Lance. by Morningstar
- Clorox Poised to Boost Investments to Support Edge, With Tax Savings No Longer Hidden in the Valley by Morningstar
- We think General Mills has amassed a wide moat but expect center-store challenges to continue. by Morningstar
- Infineon Reports Decent 1Q Results Despite Currency Headwinds; Maintain EUR 20 Fair Value Estimate by Morningstar
- Full Steam Ahead for Azure, Office 365 as Microsoft Delivers Stellar 2Q Results; Raising FVE to $106 by Morningstar
- Despite Wireless Growth, Shaw Posts Weaker-Than-Expected Cable Margin; Lowering FVE to CAD 25 by Morningstar
- Initiating Coverage of Teleflex With No Moat and Stable Trend Ratings; Shares Overvalued by Morningstar
- Williams looks to benefit from higher Marcellus/Utica gas production over the next few years. by Morningstar
- Shell’s 4Q Cash Flow Disappoints, but Don’t Fret: Long-Term Targets Remain Achievable by Morningstar
- Increasing Komatsu’s FVE to JPY 3,700 on Better Mining Outlook for 2018; Stock Is Overvalued. by Morningstar
- With its improved financial flexibility, HD Supply is buying back shares and targeting acquisitions. by Morningstar
- Despite Near-Term Positives, NetApp’s Long-Term Prospects Look Bleak; Cutting FVE to $30 by Morningstar
- CRH Continues Incremental Gains in 3Q; Acquisitions Look a Little Pricey and Synergies Questionable by Morningstar
- Infineon Reports Decent 1Q Results Despite Currency Headwinds; Maintain EUR 20 Fair Value Estimate by Morningstar
- Orphan disease status for Zeneo® Midazolam in the US by AlphaValue Corporate Services
- Sprint Reported Mixed Fiscal 3Q Results, with Weak Revenue, but Solid Margins; Shares Fairly Valued by Morningstar
- Recapping 4Q Results for Integrated OFS Companies; Halliburton Presents Prime Selling Opportunity by Morningstar
- China Cord Blood buyout back in play by MCM Partners